tiprankstipranks
Atara Biotherapeutics reports Q1 EPS (23c), consensus (26c)
PremiumThe FlyAtara Biotherapeutics reports Q1 EPS (23c), consensus (26c)
2M ago
Atara Biotherapeutics price target lowered to $2.30 from $4.80 at Stifel
PremiumThe Fly
Atara Biotherapeutics price target lowered to $2.30 from $4.80 at Stifel
3M ago
Atara Biotherapeutics Board Member Decides Not to Seek Re-Election
PremiumCompany Announcements
Atara Biotherapeutics Board Member Decides Not to Seek Re-Election
3M ago
Atara Biotherapeutics submits IND for ATA3219 to treat Lupus Nephriti
PremiumThe FlyAtara Biotherapeutics submits IND for ATA3219 to treat Lupus Nephriti
5M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Atara Biotherapeutics, Pierre Fabre announce publication of ALLELE data
PremiumThe Fly
Atara Biotherapeutics, Pierre Fabre announce publication of ALLELE data
5M ago
Atara Biotherapeutics to present ‘positive’ tab-cel data during ESMO session
PremiumThe FlyAtara Biotherapeutics to present ‘positive’ tab-cel data during ESMO session
7M ago
Atara Biotherapeutics price target lowered to 40c from $1.40 at Citi
PremiumThe Fly
Atara Biotherapeutics price target lowered to 40c from $1.40 at Citi
8M ago
Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100